CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of Early Dose Escalation Using Extended-Release Tacrolimus (Envarsus XR®) to Reduce Acute Rejection and Donor Specific Antibodies in African American Renal Transplant Recipients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04665310
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:44.808071+00:00
Published At: 2025-03-14T00:00:00+00:00
Record Updated At: 2025-03-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Kidney Disease, End-Stage", "Donor Specific Antibodies", "Acute Rejection of Renal Transplant"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-03-14"
protocolSection.identificationModule.nctId: "NCT04665310"
protocolSection.identificationModule.officialTitle: "Evaluation of Early Dose Escalation Using Extended-Release Tacrolimus (Envarsus XR\u00ae) to Reduce Acute Rejection and Donor Specific Antibodies in African American Renal Transplant Recipients"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.